glp-1 news today oct 2 2025 ISPOR 2025: Exploring reasons for discontinuation Can one drug do it

Aches typically start around week 4, peak at month 2-3 during the 7.5mg dose transition, and 90% of cases resolve by month 4 with proper hydration and electrolyte management

Non-Invasive : As an injectable or oral medication, GLP-1 agonists offer a non-surgical option for individuals who may not be ready or eligible for bariatric surgery

77,78 Surprisingly, previous studies have confirmed the protective effect of smoking on UC, but it has likewise been suggested that active smoking can increase the incidence of adverse effects in the treatment of UC patients

There are no waiting rooms or hidden feesjust a dedicated team of specialists ready to support you 24/7